APA (7th ed.) Citation

T, S., T, K., N, M., T, T., Y, U., Y, M., . . . H, M. (2025). Survival Impact of Adjuvant Nivolumab Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemotherapy with Docetaxel Plus 5-Fluorouracil and Cisplatin. Annals of surgical oncology, 32(8), 5887. https://doi.org/10.1245/s10434-025-17332-7

Chicago Style (17th ed.) Citation

T, Sugase, et al. "Survival Impact of Adjuvant Nivolumab Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemotherapy with Docetaxel Plus 5-Fluorouracil and Cisplatin." Annals of Surgical Oncology 32, no. 8 (2025): 5887. https://doi.org/10.1245/s10434-025-17332-7.

MLA (9th ed.) Citation

T, Sugase, et al. "Survival Impact of Adjuvant Nivolumab Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemotherapy with Docetaxel Plus 5-Fluorouracil and Cisplatin." Annals of Surgical Oncology, vol. 32, no. 8, 2025, p. 5887, https://doi.org/10.1245/s10434-025-17332-7.